The exciting news about Tandem Diabetes Care (NASDAQ: TNDM) will be shared on Wednesday 6th November 2024. Investors and analysts are eagerly waiting to hear about the company's financial performance for the third quarter of 2024. This significant announcement will happen after market close.
According to predictions from financial analysts on Wall Street, the company is expected to report an estimated per share $0.40 loss for the quarter. Furthermore, the company is anticipated to unveil a total revenue of $223.66 million during this period.
Wall Street analysts have offered their forecasts for the company's yearly performance, predicting a total revenue of $890.98 million. At the same time, they are expecting the company to achieve per share loss of $1.72 for the fiscal year ahead.
During the same quarter of the previous year, the company's earnings report indicated a per-share loss of $0.38. Moreover, the company generated a total revenue of $185.62 million during that specific quarter.
The business has scheduled a conference call on 6th November 2024 at 04:30 PM eastern time to discuss Q3 financial results.
Throughout Friday's trading, Tandem Diabetes Care (TNDM) shares fluctuated between $31.10 and $32.13, with a trading volume of 883.30 thousand shares. The stock ended the regular trading session at $31.91, demonstrating an advance of 1.72 percent.
